Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized …

https://adir.tums.ac.ir/article/Comparing-efficacy-and-safety-of-P013,-a-proposed-pertuzumab-biosimilar,-with-the-reference-product-in-HER2–positive-breast-cancer-patients:-a-randomized-…

pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized … Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a...